Cholangiocarcinoma (CCA), a malignant tumor of the bile duct, is a major public health
problem in many Southeast Asian countries, particularly Thailand. The slow progression …

Biliary tract cancers (BTCs), including cholangiocarcinoma and gallbladder carcinoma,
originate from the biliary epithelium and have a poor prognosis. Surgery is the only choice …

Malignancy represents substantial morbidity and mortality in patients with primary sclerosing
cholangitis (PSC). This subset of patients has been proven to be at increased risk for …

The authors describe a rapid, low-cost and sensitive approach for the determination of
carbohydrate antigen 19–9 (CA 19–9) in whole blood by using magnetized carbon …

The non-invasive differentiation of malignant and benign biliary disease is a clinical
challenge. Carbohydrate antigen 19-9 (CA19-9), leucine-rich α2-glycoprotein (LRG1) …

Simple Summary A liquid biopsy has the characteristics of low trauma and easy acquisition
in the diagnosis of cholangiocarcinoma. Many researchers try to find diagnostic or …

Primary sclerosing cholangitis is a chronic, progressive cholangiopathy that frequently
affects men and is associated with inflammatory bowel disease. Although the cause of the …

Background: Cholangiocarcinoma (CCA) represents the second most common primary liver
malignancy. The incidence rate has constantly increased over the last decades and CCA …

Intrahepatic cholangiocellular carcinoma (ICC) is a challenging malignancy marked by
subtle early symptoms and a high mortality rate, making effective diagnostic markers crucial …

Cholangiocarcinoma (CCA) is a devastating malignancy that is difficult to treat because of its
insensitivity to conventional therapies and the inability to detect early tumor formation. Novel …